CLINICAL_TRIALS
trial_result
· 2023-05-16
Clinical Trial Update: A Confirmatory Safety and Efficacy Study of BBI-4000 in Subjects With Axillary Hyperhidrosis [Phase 2]
Summary
Phase 2 confirmatory safety and efficacy study of BBI-4000 in axillary hyperhidrosis completed with posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Botanix Pharmaceuticals | Conditions: Hyperhidrosis | Phase 2 | Status: COMPLETED | Results posted: 2023-05-16